BP1.15205: New Oral Medication Study

We are testing a new medication called BP1.15205 in healthy volunteers to see how safe it is and how it works in the body. This study will help us understand its effects, including how food might change its absorption.

Safety phase (I)CardiologyNeurology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Inokura
CLINICAL PHARMACOLOGY UNIT
Tilff, Belgium
Sponsor: Bioprojet Pharma
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.